My UK KM colleague David Gurteen has recently launched a new journal entitled Global Knowledge Review. I am delighted to have been asked to be a regular contributor to the journal. You can download the inaugural edition free here. You'll find my first article on Page 4.
I'm
one of the presenters at an upcoming conference on KM in the Life
Sciences and Health Care industries. If you work in these fields, or in
KM, and can get your employer to spring for the registration fee, it
should be excellent. Blue chip list of speakers from the pharma and
biotech fields and from KM. Global purview, touching on both public and
privatized health care regimes. Intriguing high-tech approach. Should
be fun. Here is the press release with more info:
-----
The Knowledge Management in Pharma & Life Science Community
of Practice will hold their 'Integrating Knowledge in the Life Science
Product Life Cycle' Web conference starting October 18th at
http://km.colayer.net/
This launch event initiates a series of community-based virtual and
face-to-face meetings and workshops devoted to best practice in this
key industry subject running throughout 2005. The program covers the latest developments in life science product
management, strategies and best knowledge management practices. Please register for membership at http://km.colayer.net/ to participate. Details of the October program and speakers are available on the Web site.
This conference will explore current best knowledge management
strategies, practices and supporting solutions in the life science
& pharma industry that enable innovation, effectiveness and success
in the competitive market. We will address issues that include:
How can existing knowledge and intellectual property be more effectively deployed into new business situations?
How should we manage our data and knowledge around the product life cycle to maximise its value in the market place?
What
new knowledge management approaches offer greater productivity for the
individual worker? For the team? For collaborators and partners? For
communities of interest and practice?
How
should we classify our knowledge better semantically so that we may
retrieve more of what we know, is known or to determine what is not
known?
What new approaches for managing
knowledge are being created by the increasingly electronic nature of
information capture, management and collaboration? What are the legal
and regulatory risks and how do we manage them?
How
do the new standards and initiatives allowing the improved exchange and
combination of data between different systems and domains create
opportunities for improved access to knowledge?
How
can improved knowledge management help to reduce the high cost of
clinical trials and patient recruitment? How do we increase the
effectiveness of knowledge-supported healthcare delivery.
The October conference comprises keynotes by Eric Neumann (CKO,
Aventis), Debra Amidon (CEO, Entovation), Douglas Weidner (CEO, KM
Mentor) and Etienne Wenger and over thirty-five speakers from a wide
range of innovative organisations who will share their strategies,
practices and supporting solutions for implementing the best product
development and life cycle management in the pharma, life science and
healthcare industries.
Topics include: Knowledge-based Business Strategies / Pharmacovigilance /
Electronic-based R&D Systems / Discovery Informatics &
Integration / Knowledge-based Ontologies, Language & the Semantic
Web / Innovative Life Science Product Development / Knowledge Transfer
/ Grid Computing / Electronic Lab Notebooks / Collaborative KM /
Outsourcing & Partnering / Regulatory Issues in KM / Data Mining,
Analysis & Visualisation / Knowledge-based Healthcare and Patent
& Intellectual Property Issues
Conference format: All pre-recorded seminars will be made available to
registrants
at the beginning of the conference to give everyone maximum flexibility
in choosing their own time and listening/viewing order for listening to
the talks, Discussion and contact through the conference web site and
teleconferences. The presentations are divided into nine sessions, each
will hold a
teleconference for discussion and questions & answers between
October 20 and 28th. You can join these live or submit your comments or
questions beforehand, and subsequently listen to the recordings. The
scheduled times for these teleconferences are available on the
conference site.
MADE IN CANADA
trust your
instincts 
My UK KM colleague David Gurteen has recently launched a new journal entitled 
